- Trials with a EudraCT protocol (33)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
33 result(s) found for: Chronic wasting disease.
Displaying page 1 of 2.
EudraCT Number: 2009-014657-32 | Sponsor Protocol Number: 2866-007 | Start Date*: 2009-12-02 | ||||||||||||||||
Sponsor Name:Merck & Co., Inc. | ||||||||||||||||||
Full Title: "A Phase IIa Randomized, Placebo-Controlled, Parallel Group, Clinical Trial to Study the Efficacy and Safety of MK-2866 in Women with Moderate to Severe Chronic Obstructive Pulmonary Disease Partic... | ||||||||||||||||||
Medical condition: Chronic obstructive pulmonary disease-related muscle wasting Enfermedad pulmonar obstructiva crónica relacionada con desgaste muscular | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-001550-14 | Sponsor Protocol Number: ECP-GVHD1 | Start Date*: 2015-06-09 | |||||||||||
Sponsor Name:Bispebjerg hospital | |||||||||||||
Full Title: Extracorporeal Photopheresis Treatment in steroid refractory acute and chronic Graft versus Host Disease | |||||||||||||
Medical condition: Acute and chronic Graft versus Host Disease (GVHD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-006178-86 | Sponsor Protocol Number: EBMT-LE-0601 | Start Date*: 2007-08-03 | |||||||||||
Sponsor Name:European group for Blood and Marrow Transplantation | |||||||||||||
Full Title: A randomized placebo-controlled trial comparing cyclosporine plus steroids with or without Myfortic® as primary treatment for extensive chronic graft-versus host disease | |||||||||||||
Medical condition: patients with newly diagnosed (first episode) extensive chronic Graft versus Host Disease (cGvHD) post allogeneic transplantation for any primary diagnosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) NL (Prematurely Ended) ES (Ongoing) SE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001892-12 | Sponsor Protocol Number: 00557 | Start Date*: 2007-10-15 | |||||||||||
Sponsor Name:University Medical Centre Freiburg | |||||||||||||
Full Title: Everolimus and mycophenolate as GvHD-prophylaxis in the allogenous blood stem cell transplantation (Everolimus und Mycophenolsäure als GvHD-Prophylaxe in der allogenen Blutstammzelltransplantation) | |||||||||||||
Medical condition: Prophylaxis of graft-versus-host disease after allogenous blood stem cell transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005019-81 | Sponsor Protocol Number: INO-0106 | Start Date*: 2006-12-22 | |||||||||||
Sponsor Name:OPi | |||||||||||||
Full Title: A European Open-Label, Multicentre, Phase II Study of Inolimomab in the Treatment of Primary Steroid Resistant Acute Graft versus Host Disease (aGvHD) following allogeneic Stem Cell Transplantation... | |||||||||||||
Medical condition: For treatment of patients with Primary Steroid Resistant Acute Graft versus Host Disease (aGvHD) following allogeneic Stem Cell Transplantation for Hematological Malignancies in Adult patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004118-33 | Sponsor Protocol Number: trapiantoover66 | Start Date*: 2013-06-17 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: High-dose cyclophosphamide role in the prophylaxis of GVHD in elderly patients (66-70 years) with acute leukemia or myelodysplasia high-risk, submitted to allogenic transplant of peripheral hematop... | |||||||||||||
Medical condition: Elderly patients (66-70 years) with acute leukemia or high-risk MDS who, underwent allogenic transplant of peripheral hematopoietic progenitors after reduced-intensity conditioning. | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000101-11 | Sponsor Protocol Number: ProfGVHD | Start Date*: 2008-04-02 | |||||||||||
Sponsor Name:OSPEDALE POLICLINICO S. MATTEO | |||||||||||||
Full Title: Multicenter, prospective, randomized clinical trial to assess two different doses of anti-human-T-lymphocyte immune serum preparation derived from rabbit in GVHD profilaxis in pediatric population ... | |||||||||||||
Medical condition: graft versus host disease profilactic use | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004067-53 | Sponsor Protocol Number: Thymo-06 | Start Date*: 2006-09-05 | |||||||||||
Sponsor Name:OSPEDALE POLICLINICO S. MATTEO | |||||||||||||
Full Title: A multicenter randomized study on the use of rabbit anti-T-Lymphocite globulin ATG different doses to prevent GVHD in children receiving allogenic stem cell transplantation | |||||||||||||
Medical condition: ematological malignant neoplasm | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004847-35 | Sponsor Protocol Number: PredEver_first | Start Date*: 2012-09-07 | ||||||||||||||||||||||||||
Sponsor Name:University Medical Center Hamburg-Eppendorf | ||||||||||||||||||||||||||||
Full Title: Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first) - A prospective multicenterphase IIA study - | ||||||||||||||||||||||||||||
Medical condition: chronic Graft versus Host Disease | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-022780-35 | Sponsor Protocol Number: 10-005 | Start Date*: 2011-07-06 | |||||||||||
Sponsor Name:THERAKOS, Inc. | |||||||||||||
Full Title: A Randomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy with UVADEX™ for the Treatment of Patients with Moderate to Severe Chronic Graft-versus-Host Disease (cGvHD) | |||||||||||||
Medical condition: Chronic graft-versus-host disease (cGvHD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) AT (Completed) ES (Completed) IT (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002503-26 | Sponsor Protocol Number: X16082 | Start Date*: 2017-03-14 | ||||||||||||||||
Sponsor Name:Fundación Pública Andaluza para la Gestión en Salud de Sevilla (FISEVI) | ||||||||||||||||||
Full Title: Phase Ib/II trial to evaluate safety and efficacy of oral ixazomib in combination with sirolimus and tacrolimus in the prophylaxis of chronic graft-versus-host disease | ||||||||||||||||||
Medical condition: Adult patiens after allogeneic stem cell transplantation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-024297-19 | Sponsor Protocol Number: TJB1016P1 | Start Date*: 2011-09-13 | ||||||||||||||||
Sponsor Name:CHU de Liege | ||||||||||||||||||
Full Title: Allogeneic hematopoietic cell transplantation from HLA-matched donors after reduced-intensity conditioning: a phase II randomized study comparing 2 GVHD prophylaxis regimen | ||||||||||||||||||
Medical condition: Hematologic malignancies treated by reduced-intensity conditioning allogeneic transplants. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000894-22 | Sponsor Protocol Number: MAGIC-HR-ECP | Start Date*: 2019-12-10 | |||||||||||
Sponsor Name:Department of Stem Cell Transplantation - University Medical Center Hamburg-Eppendorf | |||||||||||||
Full Title: Phase II multicenter study of extracorporeal photopheresis with UvadexTM plus standard steroid treatment for high risk acute Graft-versus-Host Disease | |||||||||||||
Medical condition: New onset high risk acute GvHD following allogeneic SCT | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004310-14 | Sponsor Protocol Number: TJB0703 | Start Date*: 2007-12-13 | |||||||||||||||||||||
Sponsor Name:CHU-ULG | |||||||||||||||||||||||
Full Title: Infusion of mesenchymal stem cells as treatment for steroid resistant grade II to IV acute GVHD or poor graft function: a multicenter phase II study | |||||||||||||||||||||||
Medical condition: Steroid resistant grade II to IV acute graft-versus-host disease (GVHD) or poor graft function after allogeneic hematopoietic cell transplantation | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: BE (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018594-37 | Sponsor Protocol Number: EMN-alloRIC2010 | Start Date*: 2013-01-24 | ||||||||||||||||
Sponsor Name:European Myeloma Network | ||||||||||||||||||
Full Title: European Myeloma Network sequential phase I / phase II trial on RIC allogeneic transplantation: an optimized program for high risk relapsed patients | ||||||||||||||||||
Medical condition: Allogeneic transplantation for patients with multiple myeloma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004431-38 | Sponsor Protocol Number: P15099 | Start Date*: 2009-02-20 | |||||||||||
Sponsor Name:Imperial College | |||||||||||||
Full Title: ACE inhibition and mechanisms of skeletal muscle weakness in COPD | |||||||||||||
Medical condition: Chronic obstructive pulmonary disease patients who have skeletal muscle weakness. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006577-25 | Sponsor Protocol Number: 070101 | Start Date*: 2007-07-25 | |||||||||||
Sponsor Name:Karolinska Institutet | |||||||||||||
Full Title: A prospective randomized study comparing rapamune and tacrolimus vs. cyclosporine and methotrexate as immune prophylaxis in allogeneic hematopoietic stem cell transplantation, using HLA-A, -B, -DRB... | |||||||||||||
Medical condition: Graft versus host disease prophylaxis in patients receiving stem cell transplantation due to: chronic myeloid leukemia (CML) in 1st or 2nd chronic phase, acute myeloid leukemia (AML) in complete re... | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) FI (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006948-65 | Sponsor Protocol Number: Version 4 | Start Date*: 2007-11-29 |
Sponsor Name:University Hospitals of Leicester NHS Trust | ||
Full Title: The effect of acidosis correction and exercise on tissue wasting and immune function in renal patients | ||
Medical condition: Chronic kidney disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-004267-20 | Sponsor Protocol Number: RIG-P000814 | Start Date*: 2016-09-01 | |||||||||||
Sponsor Name:Medical Center - University of Freiburg | |||||||||||||
Full Title: Multicenter, randomized Phase 2 Trial to determine the Response Rate of Ruxolitinib and Best Available Treatment (BAT) versus BAT in Steroid-refractory acute Graft-versus-Host Disease (aGvHD) | |||||||||||||
Medical condition: Steroid-refractory acute Graft-versus-Host Disease (GvHD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-003540-11 | Sponsor Protocol Number: HO96GVHD | Start Date*: 2010-02-24 | |||||||||||
Sponsor Name:HOVON Foundation | |||||||||||||
Full Title: Prevention of severe GVHD after allogeneic hematopoietic stem cell transplantation, applied as consolidation immunotherapy in patients with hematological malignancies. A prospective randomized phas... | |||||||||||||
Medical condition: Graft versus Host Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) BE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
